ACUTE ASCENDING MYELITIS AND ENCEPHALOPATHY AFTER INTRATHECAL CYTOSINE-ARABINOSIDE AND METHOTREXATE IN AN ADOLESCENT BOY WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
A. Ozon et al., ACUTE ASCENDING MYELITIS AND ENCEPHALOPATHY AFTER INTRATHECAL CYTOSINE-ARABINOSIDE AND METHOTREXATE IN AN ADOLESCENT BOY WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Brain & development, 16(3), 1994, pp. 246-248
A 14-year-old boy with acute lymphoblastic leukemia developed acute as
cending myelitis followed by encephalopathy after intrathecal administ
ration of methotrexate 15 mg and cytosine arabinoside 50 mg. The patie
nt had none of the risk factors noted previously in other patients wit
h intrathecal therapy (IT) induced neurotoxicity. The doses administer
ed were within the standard scales, and toxicity developed in the seco
nd boost of IT 20 days after the first one. There may not be any param
eters to predict the occurrence of such severe and rare form of CNS ne
urotoxicity attributed to IT.